Mechanism of Action ITI-333, a Novel Modulator of Serotonin, Dopamine, and Mu Opiate Receptors for the Treatment of Pain and Psychiatric Co-Morbidities Accompanying a Broad Spectrum of Substance Use Disorders
NEUROPSYCHOPHARMACOLOGY（2017）
Key words
Alcohol and Substance Use Disorders,Mood and Addiction,5-HT2A Receptor,Mu-Opioid Receptors,Psychiatric Comorbidity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined